Allied Biotech Corporation (TPEX:1780)
Taiwan · Delayed Price · Currency is TWD 24.80
+0.75 (3.12%)
Aug 19, 2026, 1:30 PM CST
Allied Biotech Market Cap
Allied Biotech has a market cap or net worth of 2.31 billion as of August 19, 2026. Its market cap has increased by 38.93% in one year.
Market Cap
2.31B
Enterprise Value
1.85B
Revenue
922.49M
Ranking
n/a
PE Ratio
12.98
Stock Price
24.80
ChartMarket Cap Chart
Since April 29, 2010, Allied Biotech's market cap has increased from 1.27B to 2.31B, an increase of 81.61%. That is a compound annual growth rate of 3.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 2.31B | 4.11% |
| Dec 31, 2025 | 2.22B | 33.44% |
| Dec 31, 2024 | 1.67B | 5.41% |
| Dec 29, 2023 | 1.58B | 17.93% |
| Dec 30, 2022 | 1.34B | -7.84% |
| Dec 30, 2021 | 1.45B | -9.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| LIWANLI Innovation | 4.33B |
| Tien Liang BioTech | 4.22B |
| Orient EuroPharma | 4.16B |
| Yoda Pharmaceuticals | 3.81B |
| Easywell Biomedicals | 3.74B |
| Maywufa Company | 2.75B |
| Johnson Chemical Pharmaceutical Works | 2.41B |
| Merdury Biopharmaceutical | 2.29B |